Evidence map›Paper›PMID 40671556›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Amyloid-β protein precursor modulates mitophagy and mitochondrial function through its cellular localization.

Taylor A Strope, Benjamin Troutwine, Brittany M Hauger, Keith P Smith, Russell H Swerdlow, Heather M Wilkins

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Taylor A StropeDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Benjamin TroutwineUniversity of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Brittany M HaugerUniversity of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Keith P SmithUniversity of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Russell H SwerdlowDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Heather M WilkinsDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JONATHAN D MAHNKEN · 2021 to 2026
$25.3M
Relationships between APP and MitochondriaR01AG078186 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Heather M. Wilkins · 2023 to 2026
$2.9M
Interactions between Mitochondria, ER, and AmyloidF31AG084298 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI STROPE, TAYLOR A. · 2023 to 2025
$113k
NIA NIH HHS F31 AG084298NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG078186
6 · The paper itself

Abstract

BackgroundAmyloid-β (Aβ) is generated from amyloid-β protein precursor (AβPP) via secretase enzymes. While AβPP processing and its localization are well understood, the function of AβPP is largely unknown. AβPP has been shown to localize to mitochondria, but the consequence of this is not understood.ObjectiveWe examined the consequences of modulating mitochondrial AβPP content on mitochondrial function.MethodsWe measured mitochondrial AβPP localization in postmortem human brain from non-demented and AD subjects. To understand the effects of mitochondrial localization of AβPP on mitochondria, we leveraged AβPP constructs with increased (D23A) or decreased (3 M) mitochondrial localization compared to a wild-type (WT) construct. We measured mitochondrial function including dynamics and mitophagy.ResultsWe observed increased AβPP mitochondrial localization in postmortem brain of sporadic AD subjects. Increased or decreased mitochondrial AβPP content led to reduced electron transport chain (ETC) activities, reduced ATP levels, increased mitochondrial superoxide production, hyperpolarized mitochondrial membrane potential, and increased mitochondrial calcium content. Reduced mitochondrial AβPP content reduced mitophagy flux, while increased mitochondrial AβPP content increased mitophagy flux. Increased or decreased mitochondrial AβPP content reduced mitochondrial biogenesis. We identified interactions between AβPP and mitophagy/autophagy proteins. We next examined if a specific motif in AβPP was responsible for alterations in mitochondrial function and mitophagy. Mitophagy flux was inhibited with expression of ΔCT AβPP, suggesting a role for the C-terminus of AβPP in mitophagy induction.ConclusionsOverall, these findings highlight a critical role of AβPP in mitochondrial physiology. Alterations to AβPP mitochondrial content can lead to mitochondrial dysfunction.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorBrainMitochondriaMitophagyAgedAged, 80 and overFemaleHumansMaleMembrane Potential, MitochondrialAmyloid beta-Protein PrecursorAlzheimer's diseaseamyloid-βamyloid-β protein precursormitochondriamitophagy

Identifiers

PMID40671556
PMCPMC12643050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.